- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03709069
Effect of Enteral Albumin on Healing of Superficial Partial Thickness Fresh Flame Burns of Adults
Patients with 10 to 20% Superficial partial thickness fresh flame burn will be recruited. Burn thickness will be confirmed by using Laser Doppler. After randomly allocating into two groups, one group will receive enteral supplemental albumin in the form of boiled egg along with routine diet while other group will receive only routine diet.
Effect of burn healing will be noted in terms of epithelization, oedema, pain and redness and days of hospital stay
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Burn is an insult to the living tissues typically skin leading to coagulative necrosis due to extreme of temperature, electricity or chemicals. Burn injuries are a global public health problem with physical, psychological, social and economic implications on patients, their families and society as a whole. According to WHO, about 265,000 people die each year due to burn injuries. Vast majority of burn cases occur in middle and low socioeconomic groups of society. Any age group can be the victim of burn but people belonging to actively working class i.e. young adults (18-40yr) are more susceptible to burn injury. The most common sites of burn occurrence are domestic kitchen and workplaces from upset of receptacles containing hot liquids or directly from flames, electricity or cook stove burst.
Skin has outer covering of epidermis and deeper one is dermis. Burns, from management point of view, can be classified into superficial, superficial partial thickness, deep partial thickness and full thickness depending upon the extent of layers of skin involved. Superficial burns do not need specialized treatment and heal by their own while deep partial thickness and full thickness burns mostly require surgical procedures for management. Patients having superficial partial thickness burn wounds are the group of particular interest in burn centers due to two reasons. Firstly, the majority of burn injuries fall in this group and secondly, these are the wounds which, if managed well, heal in three weeks satisfactorily without any surgical intervention. The superficial partial thickness burn wounds involve damage to epidermis as well as partial dermis and characterized by Slough (yellowish white fibrinous tissue containing proteinacious material, pus and fibrin on wound surface), Erythema (redness of burn skin surface), Ooze (excessive fluid loss).
According to American Burn Association recommendations, patients having superficial partial thickness burn more than 10% body surface area need hospitalization for management. Multiple factors play role in the healing of superficial partial thickness burn wounds like age, co-morbidities (diabetes, HTN, obesity etc), immunosuppressive medications (steroids, chemotherapy) and nutritional status. Management of superficial partial thickness burn wound requires pain management, dressings, topical ointments and culture guided antibiotics. Despite of all these maneuvers, good nutritional support in the form of both micronutrients and macronutrients particularly proteins are critical component of acute burn wound care. Early optimal nutrition administration in management of burn patients particularly involves proteins rich diet due to lot of oozing from large wound surface area, high catabolism of muscles and vast tissue repair.
Protein enrichment of diet, for burn patients, can be achieved by adding albumin, which is easily available from many sources especially egg and plays vital role in burn wound healing. Albumin, synthesized by liver, is one the major proteins which has several important functions. Albumin, composed of essential amino acids, is primary serum binding protein required for transportation of various substances in blood circulation. Albumin administration is much easier through enteral route. Deficit of albumin occurs due to decreased synthesis during inflammatory conditions and, in burns, is further augmented by a shift in distribution of albumin to interstitial space from vascular compartment. A deficiency of albumin level can impair burn wound healing process whereas increased albumin level does not cause significant clinical complication. Hypo-albuminemia caused by wound exudation is the major predictor after injury that results in shock induction secondary to major extracellular fluid loss by increasing vascular permeability.
The rationale of this study is to find out effects of albumin supplementation on hospital stay by affecting healing of superficial partial thickness burn wounds by.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54000
- Recruiting
- Mayo Burn Center
-
Contact:
- Afzaal Bashir, FCPS, MPhil
- Phone Number: +923064000110
- Email: dr.afzaal@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 10-20% superficial partial thickness flame burn determined by LASER Doppler.
- Age between 18-40years.
- Fresh burn wound
- Patient with BMI ranging from 18.9-24.9.
Exclusion Criteria:
- Patient not willing to participate
- Any co-morbidities (i.e. DM, HTN, CRF, CCF, CLD)
- Patient with abnormal baseline serum albumin levels
- Patients not taking diet from hospital kitchen
- Patient known allergic to albumin
- Patient put on nil per oral (NPO)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Traditional Group
Traditional group receives diet from hospital kitchen quantity of which calculated depending on calorie requirement per kg body weight. This diet is same for all burn patients fulfilling the inclusion criteria of the study and it will be labelled as routine diet. Wounds of patients will be managed by closed dressing to be changed on every third day. |
|
|
EXPERIMENTAL: Albumin Group
Interventional group receiving enteral supplemental albumin 2mg per kg body weight along with routine hospital kitchen diet same as group A and same wound management with closed dressing to be changed on every third day similar to group A.
|
Enteral supplementation by albumin of boiled egg as 2mg per kg body weight.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound epithelization
Time Frame: 3 weeks
|
Wound epithelization will be assessed by photographic image analysis.
Serial photographs of wound will be taken on every third day and will be assessed by two independent blinded plastic surgeons to rate for epithelization.
The process will be continued till complete epithelization is witnessed.
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect on pain: PRS
Time Frame: 3 weeks
|
Pain will be assessed using Numeral Rating Scale (PRS) by score of 10.
Score of 0 will be taken as no pain and score of 10 as maximum pain felt ever by the patient.
Pain scoring will be done on every third day till complete healing of wound is acheived.
|
3 weeks
|
|
Change in Oedema
Time Frame: 3 weeks
|
Will be assessed clinically as well as by measuring the girth of the area on every third day and change will be recorded
|
3 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Afzaal Bashir, FCPS,MPhil, KEMU Lahore
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Alb-burn
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Partial-thickness Burn
-
Dr Muhammad Naveed ShahzadNot yet recruitingSilver Sulfadiazine With Hyaluronic Acid Versus Silver Sulfadiazine Alone in Partial-Thickness BurnsPartial-Thickness Burn, Thermal BurnPakistan
-
Amarantus BioScience Holdings, Inc.Amarex Clinical ResearchUnknownThermal Injury | Deep Partial-Thickness Burn | Full-Thickness BurnUnited States
-
Molnlycke Health Care ABRecruitingPartial-thickness BurnUnited States
-
University of TennesseeMedline IndustriesCompletedBurns | Partial-thickness BurnUnited States
-
KeraNetics, LLCUnited States Department of Defense; Wake Forest UniversityTerminatedPartial-thickness BurnUnited States
-
Nanomedic Technologies Ltd.CompletedPartial Thickness BurnIsrael
-
Cellution BiologicsNot yet recruiting
-
Avita MedicalActive, not recruitingSurgical Wound | Partial-thickness Burn | Autografts | Trauma Wound | Partial Thickness WoundsUnited States
-
Chulalongkorn UniversityNational Science and Technology Development Agency, ThailandCompletedDeep Partial Thickness BurnThailand
-
GeneScience Pharmaceuticals Co., Ltd.Third Military Medical University; Shanghai Jiao Tong University School of... and other collaboratorsCompletedDeep Partial Thickness Burn
Clinical Trials on Albumin supplementation
-
University College, LondonRecruiting
-
University of ThessalyCompletedPostbiotics SupplementGreece
-
Université de SherbrookeUnknownSystolic Heart Failure | Sub-clinical HypothyroidismCanada
-
University of ThessalyCompletedPostbiotics SupplementationGreece
-
Maastricht University Medical CenterBioActor B.V.Active, not recruiting
-
Gümüşhane UniversıtyCompleted
-
University of Missouri-ColumbiaAlmond Board of CaliforniaCompleted
-
Charite University, Berlin, GermanyFreie Universität Berlin, Institute of Biology/Genetic, Berlin,Germany; Karl-Franzens-Universität...CompletedSubjective Cognitive DeclineGermany
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedEsophagitis | Mucositis | Malignant NeoplasmUnited States
-
First Affiliated Hospital of Chongqing Medical...Not yet recruitingDepression - Major Depressive DisorderChina